Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bassan

Showing results (31-40 of 104) with videos related to

Pageof 11
Sort By:
American Journal of Clinical Pathology|September 1, 1990
Association of NK-cell lymphoproliferative disease and nephrotic syndromeR Bassan, A Rambaldi, M Abbate, et al.
Blood|April 1, 1989
Differences in the expression of alkaline phosphatase mRNA in chronic myelogenous leukemia and paroxysmal nocturnal hemoglobinuria polymorphonuclear leukocytesA Rambaldi, M Terao, S Bettoni, et al.
Haematologica|July 11, 1998
A new combination of carboplatin, high-dose cytarabine and cross-over mitoxantrone or idarubicin for refractory and relapsed acute myeloid leukemiaR Bassan, T Lerede, M Buelli, et al.
Acta Haematologica|January 1, 1985
Danazol for the treatment of idiopathic thrombocytopenic purpuraM Buelli, S Cortelazzo, P Viero, et al.
Hematological Oncology|January 1, 1991
Short-term remission induction and consolidation therapy for adult acute myelogenous leukemiaR Battista, R Bassan, A D'Emilio, et al.
Cancer|January 1, 1989
Autoimmunity and B-cell dysfunction in chronic proliferative disorders of large granular lymphocytes/natural killer cellsR Bassan, M Pronesti, M Buzzetti, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1987
Treatment of the lymphoid blast crisis of chronic myeloid leukemiaR Bassan, R Battista, B Comotti, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Long-term results of the HEAVD protocol for adult acute lymphoblastic leukaemiaR Bassan, R Battista, A D'Emilio, et al.
Leukemia & Lymphoma|May 7, 1998
The role of idarubicin in adult acute lymphoblastic leukaemia: from drug resistance studies to clinical applicationR Bassan, B Chiodini, T Lerede, et al.
British Journal of Haematology|September 21, 2001
Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity of either drug aloneN Di Gaetano, Y Xiao, E Erba, et al.
Pageof 11

Showing results (31-40 of 104) with videos related to

Sort By:
Pageof 11
American Journal of Clinical Pathology|September 1, 1990
Association of NK-cell lymphoproliferative disease and nephrotic syndromeR Bassan, A Rambaldi, M Abbate, et al.
Blood|April 1, 1989
Differences in the expression of alkaline phosphatase mRNA in chronic myelogenous leukemia and paroxysmal nocturnal hemoglobinuria polymorphonuclear leukocytesA Rambaldi, M Terao, S Bettoni, et al.
Haematologica|July 11, 1998
A new combination of carboplatin, high-dose cytarabine and cross-over mitoxantrone or idarubicin for refractory and relapsed acute myeloid leukemiaR Bassan, T Lerede, M Buelli, et al.
Acta Haematologica|January 1, 1985
Danazol for the treatment of idiopathic thrombocytopenic purpuraM Buelli, S Cortelazzo, P Viero, et al.
Hematological Oncology|January 1, 1991
Short-term remission induction and consolidation therapy for adult acute myelogenous leukemiaR Battista, R Bassan, A D'Emilio, et al.
Cancer|January 1, 1989
Autoimmunity and B-cell dysfunction in chronic proliferative disorders of large granular lymphocytes/natural killer cellsR Bassan, M Pronesti, M Buzzetti, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1987
Treatment of the lymphoid blast crisis of chronic myeloid leukemiaR Bassan, R Battista, B Comotti, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Long-term results of the HEAVD protocol for adult acute lymphoblastic leukaemiaR Bassan, R Battista, A D'Emilio, et al.
Leukemia & Lymphoma|May 7, 1998
The role of idarubicin in adult acute lymphoblastic leukaemia: from drug resistance studies to clinical applicationR Bassan, B Chiodini, T Lerede, et al.
British Journal of Haematology|September 21, 2001
Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity of either drug aloneN Di Gaetano, Y Xiao, E Erba, et al.
Pageof 11